Portola Pharmaceuticals, Inc. (PTLA)
Over the next 13 weeks, Portola Pharmaceuticals, Inc. has on average historically risen by 7.1% based on the past 4 years of stock performance.
Portola Pharmaceuticals, Inc. has risen higher by an average 7.1% in 3 of those 4 years over the subsequent 13 week period,corresponding to a historical probability of 75%
The holding period that leads to the greatest annualized return for Portola Pharmaceuticals, Inc., based on historical prices, is 3 weeks. Should Portola Pharmaceuticals, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 132% could result.
Regeneron Pharmaceuticals, Inc. (REGN)
Over the next 13 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 10.2% based on the past 26 years of stock performance.
Regeneron Pharmaceuticals, Inc. has risen higher by an average 10.2% in 19 of those 26 years over the subsequent 13 week period,corresponding to a historical probability of 73%
The holding period that leads to the greatest annualized return for Regeneron Pharmaceuticals, Inc., based on historical prices, is 37 weeks. Should Regeneron Pharmaceuticals, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 58% could result.
June 21st Daily Market Comments
The ability to pinpoint which sectors are acting the best, even when the market is not showing any major trend, is amplified by the illustration of the chart movements in specific sectors. LABU clearly indicated the biotech sector was acting well, making stocks in that sector a viable strong trades. It also allowed for a good trade in LABU itself, either stock or options. The graphics of candlestick charts allow for pinpointing which areas of the markets are acting the best. This is why we recommend Trend Analysis.